WHAT PHILANTHROPY CAN DO THAT GOVERNMENT FUNDING USUALLY CAN’T

Government funding has an essential place in scientific research. It supports enormous amounts of work, creates infrastructure, and keeps entire fields moving. NIH and other public agencies can fund at a scale private philanthropy simply cannot match.

But large public funding systems also have constraints. They have to be accountable. They rely on established criteria, formal review processes, fixed funding cycles, and layers of oversight. There are good reasons for all of that.

The problem is that breakthrough science does not always arrive in a form that makes a review committee comfortable.

Sometimes the idea is too early. Sometimes the collaboration is unusual. Sometimes the researcher has a question worth answering but not enough preliminary evidence to prove the answer before doing the work. And sometimes the work is so new that asking for precedent misses the point entirely.

That is where philanthropy can be incredibly useful.

Philanthropy Can Move Before an Idea Is Obvious

One of the biggest differences between private philanthropy and traditional government research funding is the ability to move earlier.

Government programs often need researchers to demonstrate feasibility, produce preliminary findings, and build a strong case that the proposed work has a reasonable chance of succeeding. Again, that makes sense within that system.

But there is a contradiction buried in that model.

If researchers have to show that an idea probably works before they can get the money to find out whether it works, what happens to ideas that are genuinely new?

Some of them get stranded.

Private research philanthropy can step into that gap. We can look at an important question, a strong researcher, and a promising direction and decide that there is enough there to justify finding out more.

That does not mean funding every unconventional idea somebody puts in front of you. It means being willing to fund uncertainty when the people, question, and potential impact justify the risk.

Taking More Risk Does Not Mean Being Reckless

I think people sometimes hear “high-risk research” and assume that means throwing money at wild ideas. That is not how I look at it.

Think about an investment portfolio. You probably would not put everything into the riskiest investment you can find. You would have some investments that are more established and some with greater upside and greater uncertainty.

The portfolio works because you manage the mix. Research funding can work the same way.

Some projects should advance things we already understand reasonably well. Others should push into areas where the answer is much less obvious. The way you manage that risk is not by eliminating every uncertain idea. If you do that, you may eliminate much of the potential for discovery along with it.

You manage risk by choosing good people, asking hard questions, reviewing the science carefully, and staying involved as the work develops.

The risk we are talking about is that a hypothesis might turn out to be wrong. That is very different from taking unnecessary risk with a patient.

And a hypothesis being wrong can still teach us something valuable. Knowing what not to do can save researchers years of pursuing the wrong path.

Speed Matters More Than We Like to Admit

Scientific research is difficult enough without making every administrative process difficult too.

Traditional funding can involve long proposal cycles, fixed deadlines, multiple rounds of review, and long periods between an idea being proposed and money actually becoming available. Meanwhile, science keeps moving.

A private foundation can often make decisions differently. We can talk directly with the researcher, understand what they need, bring in outside scientific expertise when necessary, and make a decision without waiting for the next formal funding cycle.

That flexibility matters when researchers are working in fast-changing areas or when an opportunity appears that does not fit conveniently into somebody else’s calendar.

Money sitting in a process does not advance science. Money in the hands of the right researcher can.

The Best Collaboration May Not Fit a Funding Category

Research has a silo problem.

Cancer researchers work within specialties. Institutions have departments. Funding mechanisms have categories. Researchers build expertise in increasingly specific areas.

There are good reasons for specialization, but biology does not care how we organize universities.

A finding in one laboratory may have implications for another researcher studying something that, on paper, looks completely different. That is one reason I care so much about putting researchers together.

At the JKTG Foundation, we increasingly look for connections across projects and disciplines. If somebody working in one area sees something that might matter to another researcher in our portfolio, I want those people talking.

Sometimes philanthropy can support those unusual connections more easily because we are not forced to ask which traditional bucket they fit into first.

We can ask a more useful question: could putting these people together help us understand something we do not understand today?

If the answer is yes, I want to explore it.

Fund the Person, Not Just the Proposal

A beautifully written proposal does not conduct research. People do.

That may sound obvious, but funding systems can become so focused on the application that we forget the researcher behind it.

When I look at a potential project, I care tremendously about the people involved. Are they curious? Will they challenge their own assumptions? Can they adapt when the data tells them something they did not expect? Do they collaborate well? Are they asking an important question because they genuinely want the answer, or simply because it fits a funding opportunity?

Great researchers rarely follow a perfectly straight line.

The experiment changes. The data creates another question. A collaboration opens a direction nobody anticipated six months earlier.

Private philanthropy can give exceptional researchers more room to follow those signals instead of forcing the science to remain inside the four corners of an original proposal.

That flexibility can be incredibly valuable.

Philanthropy Should Fill Gaps, Not Duplicate Government

I do not believe private foundations should try to replace NIH or other government research agencies. We could not, even if we wanted to. The scale is completely different.

The more interesting question is what philanthropy can do because it is different.

We can fund an idea that is not yet ready for a massive federal grant. We can help a researcher generate the evidence that makes larger funding possible later. We can connect scientists who would not ordinarily work together. We can support tools, models, data, and infrastructure that benefit multiple projects. And we can respond faster when an opportunity deserves attention.

Perhaps most importantly, philanthropy can afford to ask questions that a larger system may consider too early, too uncertain, or too unconventional.

That is not a weakness of philanthropy. I think it is one of its greatest advantages.

The Goal Is to Make Good Science Possible

I have become less interested in whether research fits neatly into an existing system and more interested in whether the work deserves to happen.

Sometimes the system works perfectly well. Sometimes you need a workaround. Sometimes somebody has to provide the first dollars before anyone else is willing to provide the next ones. And sometimes you have to give very smart people enough room to find out whether an idea is brilliant or completely wrong.

Both answers move us forward.

Government funding is enormously important to science. Philanthropy should not try to become a smaller version of it.

We should use the freedom we have to move faster when speed matters, take intelligent risks where others cannot, connect people who should be talking, and fund important questions before the answers are obvious.

Because if private philanthropy only funds what everybody else is already willing to fund, I am not sure what advantage we are bringing to the table.